BIOTECHNOLOGY VALUE FUND L P

Holdings History for SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (SABS)

Symbol: SABS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned: 4,761,906 shares
Security Ownership %: 9.1%

BVF PARTNERS L P/IL ownership in SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS)

17 Feb 2026 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,761,906 shares of SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS). This represents 9.1% ownership of the company. In their previous filing dated 14 Nov 2025, BIOTECHNOLOGY VALUE FUND L P had reported owning 5,167,618 shares, indicating a decrease of +7.9%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BVF PARTNERS L P/IL	9.1%	-8.9%	$18,761,910	4,761,906	-405,712	-7.9%	$3.94	13G/A	31 Dec 2025	17 Feb 2026, 16:23
BVF PARTNERS L P/IL	10%		$10,386,912	5,167,618			$2.01	13G/A	30 Sep 2025	14 Nov 2025, 16:24